Bristol-Myers Squibb: Ulcer trials

The registry lists 15 Ulcer studies with Bristol-Myers Squibb as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 1 2Phase 2 7Phase 3 4No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in KoreaRecruitingNCT06073873
• A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative ColitisCompletedNCT04877990Phase 2Results posted
• A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT04613518Phase 2Results posted
• Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT03934216Phase 2Results posted
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative ColitisCompletedNCT02601300Phase 2Results posted
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative ColitisCompletedNCT02435992Phase 3Results posted
• Efficacy and Safety Study of Ozanimod in Ulcerative ColitisCompletedNCT01647516Phase 2Results posted
• A Study of Abatacept in Patients With Active Ulcerative ColitisCompletedNCT00410410Phase 3Results posted
• A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their InfantsActive, not recruitingNCT06126835
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT05644665Phase 3
• To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT03915769Phase 3
• Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative ColitisTerminatedNCT02864264Phase 1
• Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative ColitisCompletedNCT01294410Phase 2
• A Study of MDX-1100 in Subjects With Active Ulcerative ColitisCompletedNCT00656890Phase 2
• A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative ColitisCompletedNCT00295282Phase 1